Prof Christopher Sweeney

Professor Christopher Sweeney is the inaugural Director of the South Australian immunoGENomics Cancer Institute (SAIGENCI), Professor of Medicine at the University of Adelaide, and Consulting Medical Oncologist at the Royal Adelaide Hospital in Adelaide.

Prof Sweeney received his medical degree from the University of Adelaide and completed an internship at the Royal Adelaide Hospital. Prof Sweeney completed a fellowship in hematology/oncology and then joined the faculty at Indiana University Medical Center, Indiana, USA, and in 2009 moved to the Dana-Farber Cancer Institute and Harvard Medical School, Massachusetts, USA. He was promoted to Full Professor at Harvard University in 2018 and returned to Australia in 2022. Prof Sweeney was awarded a Doctor of Health Sciences from the University of Adelaide in 2023 and Fellowship of Australasian College of Physicians in 2024.

Prof Sweeney’s primary research interest is drug and biomarker discovery and development. His academic focus is primarily on the management of genitourinary malignancies, with a focus on prostate and testicular cancer translational and clinical research.